Edition:
United Kingdom

Alkermes Plc (ALKS.OQ)

ALKS.OQ on NASDAQ Stock Exchange Global Select Market

34.16USD
5:52pm GMT
Change (% chg)

$0.74 (+2.21%)
Prev Close
$33.42
Open
$33.80
Day's High
$34.37
Day's Low
$33.09
Volume
83,181
Avg. Vol
286,878
52-wk High
$71.22
52-wk Low
$32.61

Chart for

About

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central... (more)

Overall

Beta: 2.17
Market Cap(Mil.): $7,913.33
Shares Outstanding(Mil.): 153.66
Dividend: --
Yield (%): --

Financials

  ALKS.OQ Industry Sector
P/E (TTM): -- 83.62 33.60
EPS (TTM): -1.28 -- --
ROI: -12.81 -0.65 15.05
ROE: -16.00 0.07 16.62

Recro Pharma shares plummet after FDA rejects non-opioid pain shot

Recro Pharma's shares dropped more than 50 percent on Thursday after the U.S. Food and Drug Administration declined to approve the drugmaker's non-opioid shot IV meloxicam, saying the pain-relieving effect did not meet expectations.

24 May 2018

UPDATE 2-Recro Pharma shares plummet after FDA rejects non-opioid pain shot

* FDA says drug's pain-relieving effect did not meet expectations

24 May 2018

Earnings vs. Estimates